IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Willem Dafoe on ‘Poor Things’ Oscar buzz, iconic ‘Spider-Man’ role

    07:34
  • Holiday package theft on the rise as porch pirate warning issued

    04:08
  • John Brooks Slaughter, trailblazing engineer, dies at 89

    02:03
  • Woman’s journey from patient to doctor gives hope to children

    04:35
  • Grandpa falls into crib and plays it off with a bedtime snuggle

    01:50
  • Sunday TODAY fans take Mug Shot with litter of Basenji puppies

    02:10
  • NBA legend Kareem Abdul Jabbar breaks hip after fall at concert

    00:23
  • Biden open to working with GOP over immigration in policy shift

    01:52
  • Senate negotiators to hammer out Ukraine, border funding deals

    01:36
  • US military shoots down 14 Houthi attack drones targeting Israel

    00:20
  • Israeli military admits to killing 3 hostages in Gaza, stirring outrage

    02:26
  • East Coast braces for washout with flood alerts in every state

    01:50
  • Scarlett Johansson talks ‘Asteroid City’ and new skincare line

    07:45
  • Streaming bundles points to future of subscription services

    04:23
  • Thai cave survivor finds new life as a student in the US

    03:40
  • Bronka Sundstrom, Holocaust survivor and mountaineer, dies at 98

    02:23
  • Taylor Swift fans attempt to recreate her Time cover with their cats

    03:00
  • Hospice clinicians take Sunday Mug Shot in New York City

    01:40
  • Shohei Ohtani signs record-breaking contract with LA Dodgers

    00:28
  • Trump remains favorite for GOP nomination despite legal issues

    02:12

New drugs revolutionizing weight-loss and health care

04:34

The FDA has approved Zepbound, the latest in a growing number of drugs that are revolutionizing weight loss as America faces an epidemic of obesity. Will insurance companies begin to cover the cost and are doctors sure they are safe? NBC’s Liz Kreutz reports in this week’s Sunday Focus. **CORRECTION: An earlier version of this story incorrectly stated that Eli Lilly’s Mounjaro has only been approved for people with pre-diabetes. It has now been updated to reflect that Mounjaro has been approved for people with pre-diabetes and Type 2 diabetes.**